United-Guardian Q1 sales rise 16% to $2.87M; EPS $0.18 vs $0.12 YoY

UNITED GUARDIAN INC

Net income $818,902 ($0.18 per share) vs $560,895 ($0.12) in Q1 2025.
Pharmaceutical sales up 24% on Renacidin demand; cosmetic ingredient sales up 21%.
Settlement income from contract manufacturer for Renacidin shutdown in 2023 boosted results.
President sees momentum from ASI resuming regular purchases and new distribution agreements.

item 2.02item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.